SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-034785
Filing Date
2021-06-30
Accepted
2021-06-29 18:08:33
Documents
7
Period of Report
2021-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea143503-8k_inmedpharma.htm 8-K 43819
2 FORM OF SERIES A WARRANT ea143503ex4-1_inmedpharma.htm EX-4.1 98326
3 FORM OF PRE-FUNDED WARRANT ea143503ex4-2_inmedpharma.htm EX-4.2 97405
4 FORM OF SECURITIES PURCHASE AGREEMENT ea143503ex10-1_inmedpharma.htm EX-10.1 281620
5 FORM OF REGISTRATION RIGHTS AGREEMENT ea143503ex10-2_inmedpharma.htm EX-10.2 136140
6 PRESS RELEASE, DATED JUNE 29, 2021 ea143503ex99-1_inmedpharma.htm EX-99.1 13993
7 GRAPHIC ex99-1_001.jpg GRAPHIC 5348
  Complete submission text file 0001213900-21-034785.txt   679976
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211059499
SIC: 2834 Pharmaceutical Preparations